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ABSTRACT: Hydrophobically modified maghemite (γ-Fe2O3) 
nanoparticles were encapsulated within the membrane of 
poly(trimethylene carbonate)-b-poly(L-glutamic acid) (PTMC-
b-PGA) block copolymer vesicles using a nanoprecipitation 
process. This formation method gives a simple access to highly 
magnetic nanoparticles (MNPs) (loaded up to 70 wt %) 
together with a good control over the vesicles size (100 to 400 
nm). The simultaneous loading of maghemite nanoparticles and 
doxorubicin was also achieved by nanoprecipitation. The 
deformation of the vesicle membrane under an applied 
magnetic field has been evidenced by small angle neutron 
scattering. These superparamagnetic hybrid self-assemblies 
display enhanced contrast properties that open potential 
applications for Magnetic Resonance Imaging. They can also 
be guided in a magnetic field gradient. The feasibility of 
controlled drug release by radio-frequency magnetic 
hyperthermia was demonstrated in the case of encapsulated 
doxorubicin molecules, showing the viability of the concept of 
magneto-chemotherapy. These magnetic polymersomes can be 
used as efficient multifunctional nano-carriers for combined 
therapy and imaging. 
KEYWORDS: block copolymer vesicles, polymersome, 
nanoprecipitation, superparamagnetic iron oxide nanoparticles, 
maghemite, magnetic hypethermia, magneto-chemotherapy, 
multifunctional, MRI contrast agent, doxorubicin, theranostics 
Over the past decades, nanopolymeric therapeutics has 
proven to improve the effectiveness of cancer treatments in 
animal experiments.1-4 During this period, progresses in 
modern polymer (physico)-chemistry have enabled the design 
of polymeric carriers with ever higher levels of complexity 
featuring addressable chemically reactive functions, defined 
chain architectures, and controlled morphologies and sizes. 
When applied to the field of drug delivery, these features allow 
achieving and combining several desirable properties such as 
high drug loading content, controlled release, increased 
circulation half-life and targeting of pathological areas or 
specific cell receptors. Polymer nanomedicines have the 
potential to increase the shelf life of chemotherapeutics before 
administration and to improve their efficacy after 
administration.5-7 A direct consequence of the latter is the 
reduction in the dosing concentration and frequency of 
administration of the drug, hence the minimization of toxic side 
effects on healthy tissues, which are currently a major problem 
in chemotherapy. Among the different classes of polymeric 
nanomedicines, block copolymer vesicles also termed 
polymersomes offer an attractive structure for drug delivery 
applications.8-12 This block copolymer self-assembly in a 
closed bilayer has fostered a considerable attention since both 
hydrophilic and hydrophobic drugs can be loaded either in the 
aqueous lumen or in the membrane core respectively,13, 14 
thanks to a thick membrane that imparts long-term stability to 
the object. After drug loading, vesicle disruption inducing drug 
release can be either triggered by an environmental stimulus, 
such as pH, temperature, light, or oxidation,15-17 or can be the 
consequence of polymer hydrolytic or enzymatic 
degradation.18, 19 Even though a wide variety of polymer 
nanocarriers for drug delivery has shown efficient entrapment 
and controlled release of drugs in vitro, the evaluation of their 
biodistribution in vivo has become possible by non invasive 
methods. To address this issue, one strategy consists in 
incorporating imaging probes together with the drugs into the 
polymer nanoparticles. These dual polymer nanocarriers for 
simultaneous cancer imaging and treatment open the field to 
“theranostic nanomedicines”, combining diagnostic and 
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therapeutic components in an all-in-one nanoparticle.20, 21 
Imaging probes to be loaded can belong to different families 
such as visible22, 23 and NIR fluorochromes,24, radiotracers25-27 
or inorganic nanoparticles such as quantum dots,28-30 gold 
nanoparticles,31-35 or magnetic nanoparticles (MNPs).36, 37 
Among the different MNPs, the so called “ultra-small 
superparamagnetic iron oxide” (USPIO) particles are synthetic 
γ-Fe2O3 or Fe3O4 nanometric grains in a perfectly dispersed 
state (i.e. unclustered individual nanoparticles).38 As described 
in numerous review articles39-43, iron oxide MNPs also called 
USPIOs are commonly used as negative contrast-enhancing 
agents in MRI, enabling high spatial resolution acquisition, 
three-dimensional, non-invasive imaging of the human body. 
Hydrophilic “stealth” polymers are often employed to enhance 
the stability and biocompatibility of the MNPs in vivo by 
hindering their further aggregation and by an anti-fouling effect 
against proteins of the immune system called opsonins.42, 44 
Besides the MRI contrast enhancement properties attributed to 
their ability to distort strongly the magnetic field lines,45 
USPIOs can be used to kill cancer cells by their heating effect 
in radio-frequency magnetic fields. Hyperthermia (or thermal 
ablation) is identified as a promising approach in cancer 
therapy, particularly in combination with chemo- or radio-
therapy.41 A promising hyperthermia route for treating deep 
tumors consists in concentrating MNPs around and inside the 
tumor site and increasing the temperature locally through 
conversion into heat of the energy from an external alternating 
magnetic field in the range of radio frequencies 100 kHz – 1 
MHz. This magnetic hyperthermia led to an intense research 
activity both on the optimization of the conditions of treatment 
(power, concentration, geometrical parameters…)46-48 and on 
the characteristics of the USPIOs themselves (chemical nature, 
distribution of sizes…).39, 49-57 
For this purpose of obtaining multifunctional drug vectors, 
hydrophilic USPIOs have been loaded at first in the aqueous 
compartment of liposomes.58, 59 Under a permanent magnetic 
field, magnetic liposomes deform into elongated ellipsoids, as 
it was evidenced for giant unilamellar vesicles.60-62 Interesting 
studies dealt with much smaller magneto-liposomes analogous 
in sizes to the pegylated lipid vectors of the DOXIL™ 
formulation of the anticancer drug doxorubicin hydrochloride 
(DOX). To combine magnetism and thermo-sensitivity, DOX 
was encapsulated into magnetic vesicles with a lipid membrane 
initially in the gel state and becoming fluid at a temperature 
reachable by magnetic hyperthermia.63, 64 The application of a 
RF magnetic field led to massive release of encapsulated DOX 
since the magnetic hyperthermia was sufficient to reach locally 
the main chain phase transition temperature of the bilayer, 
thereby increasing the membrane permeability.65 Recently, an 
analogous study with small hydrophobic USPIOs embedded in 
the membrane of liposomes evidenced the release triggered by 
a RF magnetic field of a fluorescent dye used as a model of 
hydrophilic drug.66 The possibility to target a solid tumor by 
using magneto-liposomes and an extracorporeal magnet to 
guide them has also been reported.64, 67, 68 Despite the 
tremendous results obtained with liposomes, the morphology of 
lipid/MNP systems strongly varies with MNP and lipid 
concentrations.69 They also suffer from the classical issue of 
instability associated with lipid bilayers,70 which incite to use 
of polymersomes as an alternative to liposomes. We have 
shown for the first time that hydrophobic USPIOs can be 
loaded into polymersome membranes of PB-b-PGA and that a 
reversible variation of the membrane thickness can be induced 
by the application of a magnetic field.71-73 Later, Förster et al. 
induced the bridging of adjacent bilayers and formed multi-
lamellar hybrid polymersomes by incorporating hydrophobic 
USPIOs into PI-b-PEO bilayers at a feed weight ratio up to 20 
% sufficiently large to guide the vesicles by a magnetic field 
gradient.74 
In the present article, we describe a convenient procedure to 
prepare well-defined magnetic polymersomes featuring a 
hydrophobic internal membrane core made of the 
biodegradable block poly(trimethylene carbonate) (PTMC) and 
a polypeptide biocompatible corona of poly(L-glutamic acid) 
(PGA). Having synthesized USPIOs with the appropriate 
characteristics (size and hydrophobic coating), those were 
embedded together with the efficient antitumor drug 
doxorubicin hydrochloride (DOX) into the membrane of dual-
loaded vesicles by one-step nanoprecipitation. This process 
allowed reaching quantitative loading contents and controlling 
the final sizes with low polydispersity. The two-dimensional 
confinement of USPIOs inside the vesicular membrane was 
evidenced by small angle neutron and light scattering 
techniques and observed by atomic force and transmission 
electron microscopy. The magnetic membrane of the PTMC-b-
PGA polymersomes was shown to be reversibly deformable 
under a permanent magnetic field. The release of DOX under 
local hyperthermia conditions induced by an oscillating RF 
magnetic field was also evidenced as a proof of concept of 
magneto-chemotherapy with magnetic polymersomes. 
 
RESULTS AND DISCUSSION 
 
Characteristics of the USPIOs 
After synthesis75, size fractionation76 and surfactant 
coating77, the radius of gyration and the hydrodynamic radius 
of the USPIO nanoparticles used in this work were 
RGUSPIO=3.05±0.06 nm and RHUSPIO=4.7±0.07 nm as measured 
respectively by SANS and DLS. The ratio 
RGUSPIO/RHUSPIO=0.65 is not far from the theoretical value 0.775 
for dense spherical particles,78, 79 the gap being reasonably 
ascribed to the contribution of the surfactant layer to RHUSPIO 
only. Those sizes are in good agreement with the distribution 
measured by VSM (Supporting Information, S-d),80, 81 
described by a Log-normal law of median diameter 
DmagUSPIO=6.3 nm, width σ=0.22 and weight averaged diameter 
Dw=7.5 nm. Concerning the magnetic hyperthermia capability, 
a specific loss power (SLP) of 14 W/g was reported for 
USPIOs synthesized by the same route and of analogous 
distribution of diameters (DmagUSPIO=6.7 nm, σ=0.20, Dw=7.7 
nm) but at larger frequency (fRF=700 kHz) and  much higher 
field intensity H0 (24.8 kA/m).54 Using its expected variation 
with these parameters (~fRFH02), we estimate a SLP value of 
0.07 W/g in the conditions of biocompatible RF field used in 
this work (fRF=500 kHz and H0=2.12 kA/m). 
 
 Characteristics, structure and stability of USPIO-loaded 
vesicles 
In a previous study, the conditions of nanoprecipitation with 
the PTMC-b-PGA block copolymer were varied: choice of 
THF or DMSO as good solvent of the blocks, order (solvent 
into water or reverse) and duration of the addition...82 The 
influence of each experimental parameter was rationalized in 
order to finely tune the sizes and PDI of the vesicles. In 
addition, the PTMC block was shown to be semi-crystalline 
with an apparent melting temperature in vesicles near 34°C 
(lower that value at 37°C in the bulk) that has a strong 
influence on the size of the vesicles and on their interactions.83 
In the present study, we checked that incorporating inorganic 
nanoparticles at the nanoprecipitation step did not affect the 
self-assembly process of the diblock copolymer and that 
vesicular morphologies were still obtained.  The conditions 
were selected according to the low PDI obtained, the 
compatibility of the organic solvent and of the obtained 
vesicles’ sizes with in vivo applications. The copolymer was 
first dissolved in DMSO with or without γ-Fe2O3 USPIOs. 
Then water was added (up to 90 % of the final volume) at a 
controlled flow rate to trigger self-assembly. As the flow rate 
strongly influences the final size of the vesicles,82 we 
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considered two sets of conditions: an almost instantaneous 
addition (5 seconds) leading to small vesicles (RH=45-67 nm) 
denoted WDi and a 15 minutes-addition leading to larger ones 
(RH=187-202 nm) denoted WD15. The characteristics of 
nanoparticles’ dispersions prepared by either one or the other of 
these conditions at increasing USPIO feed weight ratios (FWR) 
are shown in Table 1. 
 
Table 1. Size and polydispersity index (PDI) of nanoparticles’ 
dispersions prepared with increasing feed weight ratios of 
USPIO relatively to copolymer. Vesicles were prepared by 
nanoprecipitation in DMSO by adding water either in 5 s 
(WDi) or in 15 min (WD15). The image is a macroscopic view 
of samples. 
 
Sample code FWR (%)  RH (nm) PDI 
WDi-0 0 67 0.07 
WDi-20 20 50 0.14 
WDi-35 35 45 0.16 
WDi-50 50 47 0.16 
WDi-70 70 52 0.18 
WD15-0 0 202 0.05 
WD15-20 20 196 0.09 
WD15-35 35 195 0.20 
WD15-50 50 187 0.22 
 
The vesicles were found homogeneous in sizes, as observed 
by small PDI values in DLS. The loading of vesicles by 
USPIOs progressively increases the PDI (while remaining low) 
and slightly decreases RH. This hydrodynamic size decrease 
(more pronounced for WDi than for WD15) and slight 
broadening of the sizes’ distribution (for both nanoprecipitation 
speeds) are ascribed to a larger hydrophobic effect when the 
copolymer is combined with USPIOs coated by surfactants, and 
thus to a larger driving force for a faster self-assembling 
process. No aggregation occurred below a critical USPIO 
FWR. Beyond this threshold value, the hydrophobic USPIOs 
began to aggregate during nanoprecipitation forming ill-defined 
macroscopic clusters that rapidly migrated to the vial walls 
when approaching a magnet. This maximum FWR was 
respectively 50 wt % for WD15 and 70 wt % for WDi. The 
larger threshold FWR with WDi vesicles compared to WD15 
ones can be ascribed to a much faster kinetics of formation, 
thereby minimizing the probability of USPIOs’ clustering 
before the completion of co-assembly with the copolymer. The 
maximum loading content of USPIOs in the membrane of the 
WDi-70 vesicles corresponds to a local volume fraction 
%1.12mbUSPIO =Φ . Interestingly, this is close to the reported 
value of 11% for the insertion of USPIOs in bilayers of 
polystyrene-b-polyacrylate, whereas larger volume fractions 
e.g. 21% lead to a morphological transition into micelles via 
nanoparticles’ clustering.84 Fully dispersed and stable 
suspensions were observed below and up to these maximum 
USPIO FWR values. In these conditions, the shelf life is longer 
than several months at room temperature. Static light scattering 
(SLS) measurements conducted on the WDi-50 sample strongly 
suggested a vesicular morphology. By drawing the Berry plot85 
over a scattering angular range from 50° to 150° and a 
concentration range from 0.2 to 1 mg/mL, we obtained the z-
averaged radii of gyration (RG,z) allowing to calculate the ratio 
ρ= RG/RH. While vesicles are characterized by ρ values close to 
1, ρ values around 0.775 are expected for spherical micelles.78, 
79 WDi-50 suspensions had a ρ value of 1.02 in good agreement 
indeed with vesicular self-assemblies. 
A further insight to the exact morphology of USPIO-loaded 
PTMC24-b-PGA19 particles in either WDi or WD15 conditions 
was brought by small angle neutron scattering (SANS) 
experiments. Figure 1 represents the intra-aggregate structure 
factor Sintra(q) of the USPIOs measured by SANS in a solvent 
mixture matching the neutron scattering length density of the 
copolymer. The shape of Sintra(q) reflects both the interactions 
between the USPIOs inside the object and the overall shape of 
their aggregates in the attractive regime.86, 87 In the small q-
regime, Sintra(q) followed a power law with a slope 
approximately -2 typical of flat samples, supporting a vesicle-
type morphology. In this q-region (Kratky-Porod regime), the 
thickness of the USPIO layer in the vesicle membrane can be 
calculated from the slope of Ln[q2×Sintra(q)] plotted vs. q2 
which is -δ2/12.88 From the experimental data, we obtained 
respectively δ=13 nm and δ=10 nm for samples WD15-50 and 
WDi-70. The vesicular membrane thus contains no more than 
one or two layers of magnetic colloids. More precisely, the data 
were properly fitted using a hollow sphere form factor with 
respectively an internal radius R=130 nm and shell thickness 
δ=12 nm for WD15-50, and R=45 nm lumen radius with 
membrane thickness δ=9 nm for WDi-70. These radii deduced 
from SANS fits agree pretty well with the hydrodynamic radii 
on Table 1 measured by DLS. At large wave-vectors, the q-4 
scaling law is typical of the Porod’s regime expected for 
nanoparticles with a smooth interface. Moreover, Sintra(q) 
presents a correlation peak around 8×10-2 Å-1 (see Figure 1), 
associated to a most probable USPIO inter-particle distance 
dmax =2π/qmax= 7.8 nm. Considering their weight-average 
diameter Dw=7.5 nm, we deduce that the USPIOs are closely 
packed inside the vesicular membrane for both WD15-50 and 
WDi-70 samples. The SANS curve of WDi-50 vesicles in D2O 
where the neutron scattering contrast of the USPIOs is almost 
matched also exhibits this correlation peak (Supporting 
Information S-c), as explained by the close-packed structure of 
holes in the copolymer membrane confining the USPIOs at a 
high local volume fraction. 
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A  B  
Figure 1. SANS curves of PTMC24-b-PGA19 vesicles WD15-50 (A) and WDi-70 (B), centrifuged then dispersed at 10 mg/mL in a 
mixture H2O:D2O (65.6/34.4 v/v). Experimental intra-aggregate structure factors Sintra(q) of USPIOs are plotted as open circles. The solid 
lines represent the simulated form factors respectively for hollow spheres of mean radius R=130 nm (PDI=0.17) with membrane 
thickness δ=12 nm (PDI=0.3) for WD15-50 (A), R=45 nm (PDI=0.35) with δ=9 nm (PDI=0.3) for WDi-70 (B). 
 
Figure 2. TEM images of USPIO-loaded vesicles prepared by nanoprecipitation. (A) Low magnification picture of WD15-50 vesicles 
(scale bar 1 µm); (B) Close-up view of a WD15-50 vesicle containing ~1500 USPIOs as measured by image analysis (scale bar 300 nm); 
(C) WDi-70 vesicles spreading on the substrate, which enables counting ~190 USPIOs on the left and ~220 USPIOs on the right (scale 
bar 100 nm); (D) Image of negatively stained WDi-50 vesicles, showing a group of vesicles laying intact on the carbon substrate (scale 
bar 50 nm); (E) Cryo-TEM image showing homogeneously dispersed WDi-50 vesicles (scale bar 200 nm). Inset: close-up view of two 
vesicles showing a mantle of respectively ~80 and ~110 close-packed USPIOs with some uncovered areas (scale bar 50 nm). 
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To summarize our SANS results, we found membrane 
thicknesses equal to 12.5±0.5 nm and 9.5±0.5 nm (either by 
scaling law or by form factor fitting) for WD15-50 and WDi-70 
vesicles respectively. Due to the chosen H2O/D2O solvent 
matching the copolymer scattering, these values represent the 
thickness of the USPIOs’ layer only. In D2O solvent were the 
neutron scattering signal originates both from the magnetic 
contrast of iron oxide and the nuclear contrast of the 
copolymer, we measured a total membrane thickness 29.1±0.6 
nm from Kratky-Porod’s plots of the data reported in the ESI 
file (figure S-c) for WDi vesicles independently of their iron 
oxide content (from 0 to 50% FWR), in accordance with the 
value 30±2 nm reported for the total membrane thickness of 
non magnetic vesicles made of PTMC24-b-PGA12 with a similar 
PTMC block of molar mass Mn=2750 g/mol.82 The 
measurement by SANS of the hydrophobic bilayer thickness 
for WDi vesicles well compares to the value δ=9.6 nm 
measured by cryo-TEM for polymersomes made of 
poly(ethylene oxide)-b-polybutadiene (noted EO26-BD46 or 
OB2) with a total molar mass of 3600 g/mol and a hydrophilic 
fraction of 28%, thus a hydrophobic block mass of 2600 g/mol 
close to the one of PTMC here.70 The 25% increase of 
hydrophobic thickness for WD15 vesicles is ascribed to the 
swelling of vesicles’ membranes by the incorporation of 
USPIOs, which was presumably not possible for WDi ones due 
to their much higher curvature. 
The WD15-50 and WDi-70 samples were further observed 
by TEM (Figure 2) and AFM (Figure 3) to confirm the 
vesicular morphology. TEM images mainly show the 
arrangement of the USPIOs because of the low electron 
scattering density of the copolymer compared to iron oxide. For 
both nanoprecipitation conditions (WD15 and WDi), hollow 
structures made of a close-packed arrangement of USPIOs 
were observed. The diameters measured on the TEM images 
2B and 2C are around 750 nm and 150 nm respectively for 
WD15-50 and WDi-70 vesicles, which is larger than two times 
their hydrodynamic radii reported on Table 1 (374 nm and 104 
nm respectively). This apparent discrepancy is ascribed to the 
total spreading of the vesicles onto the carbon substrate. The 
drying step during sample preparation and the strong wetting 
on substrates presumably induced the rupture of membranes, 
which explains the presence of fragments as well as not entirely 
closed structures.71-73 Unlike images A, B and C of Figure 2 
that were obtained by spraying the samples onto the grids, 
image D originates from a more gentle protocol combined with 
staining (see Experimental) that led to vesicles sitting intact on 
the substrate. Both images D and E (cryoTEM) show apparent 
diameters much closer to the light scattering results, 
undoubtedly confirming the proposed structure. However we 
chose to show images A, B and C in spite of the spreading 
effect, because the flattening of the membrane onto the 
substrate enables to count the USPIOs per vesicle much easily 
than with the projection of intact spherical vesicles (D and E). 
 
 
Figure 3. Tapping Mode™ AFM phase and height images of 1×1 μm surfaces of PTMC24-b-PGA19 vesicles prepared by 
nanoprecipitation WDi without magnetic nanoparticles (upper panel) and with 50 wt % USPIO WDi-50 (lower panel). The average 
heights are measured on the right by cross-sections. 
The WDi vesicles were also observed by AFM with and 
without the presence of 50 wt % USPIO. AFM phase images of 
empty vesicles (WDi-0) showed spherical vesicles, which 
aqueous interior leaked out due to drying and strong adsorption 
onto the freshly cleaved mica surface. When USPIOs were 
incorporated into the membrane (WDi-50), those presented 
multiple bright spots. The contrast of phase AFM pictures 
being proportional to the surface toughness,89, 90 we identify 
those bright spots with the hard inorganic USPIOs embedded 
within the soft polymer matrix and spatially distributed over the 
vesicular surface as large patches. The average thicknesses of 
membranes spread on mica were analyzed on the AFM height 
images. These profiles revealed that the presence of USPIOs 
increase the thickness from 8 nm to 15 nm, the difference being 
very close to the weight average inorganic diameter Dw=7.5 
nm. If the vesicles were adhering intact on the mica substrate, 
simply deflated by soft drying conditions, one would expect to 
measure an inorganic thickness equivalent to two layers of 
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USPIOs (respectively from the top and the bottom of the closed 
membrane). But the AFM images correspond to a single 
membrane thickness instead, which indicates that the vesicles 
had burst and spread onto the substrate, as depicted 
schematically in Supporting Information S-h. 
To conclude on the SANS, (cryo)TEM and AFM results, 
these measurements show that due to their hydrophobic 
coating, the USPIOs are confined in 2 dimensions within the 
membranes, between the two leaflets of the copolymer bilayer. 
Magnetization, migration and deformation under 
magnetic field of USPIO-loaded vesicles 
As for the magnetization properties, the magnetization 
curves of both individual USPIOs and USPIO-loaded vesicles 
were fitted according to Langevin’s law of paramagnetism, 
each USPIO being a giant magnetic monodomain with an 
average magnetic dipole of 8200 µB, which is also the 
approximate number of Fe3+ ions per USPIO (see Supporting 
Information S-d). On figure S-5, the VSM curve of WD15-50 
vesicles loaded with 50 wt % USPIO exhibits a plateau value 
MS/ΦmS allowing to determine a concentration 0.43 g/L of 
USPIOs very close to the expected one (0.429 g/L, taking into 
account the USPIO FWR and the dilution effect during 
dialysis). Like previously stated, the vesicular dispersions were 
homogeneous, as attested by the detection of neither aggregates 
by DLS nor clusters of bare USPIOs moving when approaching 
a permanent magnet. Altogether, these results suggested a 100 
% loading efficiency for the USPIOs at feed weight ratios 
lower than 50 % for WD15 and 70 % for WDi vesicles.91 Thus 
one can use mass conservation to deduce the values of the 
volume fraction Φ of USPIOs inside the membranes, on the 
basis of their initial weight ratio (FWR) relatively to the 
copolymer and their respective mass densities dUSPIO=5.1 g/cm3 
and dcopo=1 g/cm3. An estimate of the mean number of USPIOs 
per vesicle of radius RH and membrane thickness δ can be 
calculated according to: 
V
ΦVN
USPIO
mb
USPIOmbUSPIO
/vesicle
×
=  (1) 
where the volume of membrane is calculated by Vmb = 4π 
RH2 δ using geometrical values obtained by DLS and SANS 
respectively and VUSPIO is averaged over the size distribution 
law of diameters (πDw3/6). These calculations for each set of 
experiments gathered in Table 2 lead to estimated numbers of 
USPIOs in pretty good accordance with the values observed on 
the TEM pictures of Figure 2. 
Table 2. Characteristics of USPIO-loaded vesicles: feed weight 
ratio, hydrodynamic radius RH, local volume fraction Φ of 
USPIOs in membrane and their number N per vesicle 
calculated by equation (1) with respectively δ=13 nm for 
WD15 samples and δ=10 nm for WDi ones (SANS values). 
 
The migration of the WD15-50 vesicles under a controlled 
magnetic field gradient was also used to estimate differently the 
number of confined USPIOs averaged on a large population of 
vesicles. The assessment of the ability of magnetic 
polymersomes to be attracted and concentrated at a specific 
location in vivo is also particularly relevant. Compared to 
magnetophoresis experiments with objects of sizes around 10 
µm such as giant liposomes or biological cells,62, 92-95 a 
supplemental difficulty arose from the low value of the Peclet’s 
hydrodynamic number, which means that the magnetophoretic 
motion of the vesicles was not significantly larger than their 
Brownian motion (see the videos supplied as ESI). Usually, 
magnetophoretic measurements with such colloidal particles 
prone to thermal agitation are done by measuring light 
absorption profiles as a function of time and space.96-99 In the 
present work, we chose alternatively a statistical method to 
infer the average drift velocity Vdrift and the diffusion constant 
Dvesicle by following a large number of individual trajectories, 
as once described in a study of Brownian colloids in a liquid 
crystal.100 
 
A 
B
 
Figure 4. Video microscopy snapshot (inverted bright field 
image) superposed with the trajectories (A) during 10s of 
WD15 PTMC24-b-PGA19 vesicles loaded with 50 wt % of 
USPIOs. The vesicles were discriminated from the background 
by image analysis with the ParticleTracker plugin for ImageJ. 
The magnetophoretic mobility of the vesicles is visualized by 
the shifts between the histograms (B) of displacements in the x 
(red markers) and the y (blue markers) directions for durations 
respectively of τ=1/24=0.042 s (circles) and 2τ (diamonds). The 
arrow indicates the direction of magnetic field gradient of 
intensity dB/dz=18.5 T/m. The scale bar represents 20 µm. 
Sample 
code 
USPIO 
FWR 
(%) 
Φ
mb
USPIO  (%) RH (nm) N USPIO/vesicle  
WD15-20 20 3.8 196 1085 
WD15-35 35 6.4 195 1830 
WD15-50 50 8.9 187 2340 
WDi-20 20 3.8 50 55 
WDi-35 35 6.4 45 75 
WDi-50 50 8.9 47 110 
WDi-70 70 12.1 52 190 
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The Brownian motion appears isotropic with a unique 
translation diffusion constant Dves=1.11 µm2/s. The Stokes-
Einstein’s formula gives a hydrodynamic radius deduced by 
video-microscopy RHvideo=196 nm comparable to the value 
obtained by DLS. Due to an imperfect alignment of the 
magnetic field gradient with the x axis, we had to extract both 
coordinates of the magnetophoretic motion to calculate the total 
drift velocity: 
µm/s 09.122 =+= yxdrift VVV

 (2) 
This experimental value is compared to the theoretical 
estimate obtained by balancing the forces acting on a spherical 
magnetic vesicle at steady state in an external magnetic field 
gradient, which are the magnetophoretic force FB, and the 
viscous drag, Fv, acting against it. The two forces are given by: 
 
dz
dBmFB =  (3)  
and driftHv VRF ηπ6=  (4) 
where m is the magnetic moment of the vesicle,101 dB/dz is 
the gradient of the magnetic field, η is the viscosity of the 
solvent, RH is the hydrodynamic radius of the vesicle, and Vdrift 
is the velocity of the particle. From the exact balance of the 
magnetic and the viscous forces, we calculate a theoretical 
magnetophoretic velocity Vdrift≈0.5 μm/s for the WD15-50 
vesicles under a field gradient dB/dz=18.5 T/m. The factor 
around one-half between the expected drift velocity and the 
value Vdrift=1.09 μm/s measured experimentally cannot be 
ascribed to the statistical noise because the uncertainties of the 
average displacements were estimated at 0.4% and 1.6% for the 
histograms at τ and 2τ time steps containing respectively 64519 
and 3920 data points. As a tentative explanation, we know from 
a reported work on giant magnetic liposomes that the drag 
coefficient is enhanced compared to Stokes’ formula (4) if the 
vesicles were deformed by the field into high aspect ratio 
ellipsoids during their migration.102 Another correction 
compared to the drag coefficient of a solid sphere originates 
also from the viscous dissipation inside the fluid magnetic 
membrane, for instance if it was subjected to a “caterpillar” or 
a “crawling” motion.103 In addition to these pure hydrodynamic 
effects, the measured Vdrift higher than its expected value might 
be explained by an underestimate of the numbers of USPIOs 
per vesicle appearing in Table 2. This would occur for example 
in the case of a non negligible amount of “blank vesicles” that 
were undetected but increased the average LC of iron oxide 
inside the magnetic vesicles above the USPIO/copolymer ratio 
(FWR) used for nanoprecipitation. 
Apart from estimating the magnetic payload of the vesicles, 
the magnetophoresis experiment is also relevant to estimate 
their efficiency for magnetic guiding both in vivo and in vitro. 
Their magnetophoretic mobility in the vicinity of a strong 
NdFeB magnet is indeed of the same order of magnitude than 
values ≈1 µm/s reported by studies that evidenced the enhanced 
uptake of magnetic nanocarriers by cell cultures under field 
gradients104, 105. For in vivo experiments, it was hypothesized 
that the accumulation of magnetic colloids injected in the main 
blood stream at a specific region under magnetic field requires 
that their migration is faster than the blood velocity in the 
smallest vessels alimenting the tumor.98 However, the guiding 
of magnetic stealth liposomes injected in the caudal vein of 
mice by a strong permanent magnet applied directly on a solid 
tumor was evidenced, even though their drift velocity was 10 
µm/s only.68 A model experiment consisting in attracting 
clusters of MNPs of sub-micron diameters (330 nm) by a 
permanent magnet while they were circulating in a flow loop 
showed that they were efficiently deposited at the surface of the 
capillary near the magnet even with a stream velocity as high as 
1 cm/s.106 Therefore we believe that the USPIO loaded vesicles 
WD15-35 or WD15-50 are good candidates for such magnetic 
targeting applications, whereas the WDi vesicles might be too 
small and contain an insufficient number of USPIOs. 
The magnetic response of PTMC24-b-PGA19 vesicles with 
their membrane filled by 50 wt % (WD15-50) or 70 wt % 
USPIO (WDi-70) was also studied by anisotropic SANS under 
an applied magnetic field. Vesicles were dispersed in light 
water (H2O) in order to work in almost pure nuclear contrast 
conditions under field. The magnetic contrast of the γ-Fe2O3 
USPIOs in H2O being much lower than the nuclear contrast, the 
anisotropy of the SANS signal was not simply due to 
magnetization but reflects the spatial organization of the 
USPIOs and their possible rearrangement under magnetic field. 
The SANS patterns of WD15-50 vesicles are shown on Figure 
5 at increasing field intensities up to 1 T.  
The scattering patterns became clearly anisotropic when a 
magnetic field was applied to the sample.  The lines of iso-
intensity in the 3×10-3 – 3×10-2 Å-1 q-range were elliptical, 
elongated perpendicularly to the field direction. One possible 
scenario compatible with this asymmetry consists in the 
deformation of the hollow spheres formed by the USPIOs into 
either oblate or prolate ellipsoids symmetric by rotation along 
the field direction. However, one should keep in mind that the 
observed q-range corresponds to the length scale of the 
membrane thickness rather than to the whole size and shape of 
the vesicles.71-73  
In order to study this shape anisotropy more quantitatively, 
the scattering patterns were averaged in angular sectors around 
two directions parallel (//) and perpendicular (┴) to the magnetic 
field. Examples of the resulting intensity curves are plotted on 
Figure S-2 (Supporting Information S-b). By comparing the 
difference q⊥ - q// in these two directions relatively to the wave 
vector q0 obtained by an isotropic averaging at the same 
intensity value, an anisotropy factor could be calculated for 
each sample and each magnetic field intensity (Table 3). 
 
 
Figure 5. Anisotropic SANS patterns of WD15-50 in H2O in the q range 3×10-3 – 3×10-2 Å-1 under a magnetic field (horizontal) of 
intensity B=0 T (left), B=0.1 T (middle) and B=1 T (right). Each color corresponds to an iso-intensity range. 
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Table 3. Anisotropy factor of WD15-50 and WDi-70 vesicles 
calculated from anisotropic averaging of their SANS patterns at 
6 cm-1 iso-intensity under increasing magnetic field intensities. 
 
 
 
 
 
 
The calculated anisotropy factors confirmed the increase of 
membrane anisotropy with the applied magnetic field already 
visible on the SANS patterns. The anisotropy factor increased 
mainly between 0.1 and 0.6 T for both vesicular dispersions 
and remained almost constant up to 1 T. The plateau value 
reached at 0.6 T is ascribed to the saturation of the magnetic 
moment of a vesicle above B ≈ 0.7 T as observed on the 
magnetization curve (Figure S-5). It is worth noticing that the 
anisotropy parameter is smaller for WDi-70 than for WD15-50 
vesicles, as explained by the number of USPIOs per vesicle (12 
times smaller for WDi-70 than for WD15-50) and by the 
vesicle size (4 times smaller). Presumably due to their smaller 
size associated with a higher membrane curvature, WDi-70 
vesicles are less prone to magnetic deformation than the much 
larger WD15-50 ones. 
 
 
 
 
USPIO-loaded vesicles as contrast agents for MRI 
The efficiency of MRI contrast agents based on USPIO is 
usually assessed by measuring the T1 (longitudinal) and T2 
(transverse) relaxation times of the proton spins relaxations. 
Then the relaxation rates 1/T1 and 1/T2 are plotted versus total 
iron concentration in mM and the resulting slopes (s-1mM-1) 
called respectively r1 and r2 relaxivities can be used to compare 
different samples of USPIO differing by their size, dispersity, 
local concentration, aggregation state or any other parameter 
like the confinement in either a hydrophilic or a hydrophobic 
environment. In particular the encapsulation of USPIOs in 
hydrophobic polymers hampers the diffusion of water protons 
in the vicinity of USPIOs, which results in poor T1 contrast 
enhancement,107 so that we can infer the same effect in our 
systems where the USPIOs are buried within a hydrophobic 
membrane. In addition, r1 decreases rapidly as a function of the 
applied magnetic field (i.e. the Larmor’s resonance frequency) 
while r2 reaches a plateau value due to the so-called “secular 
term” in its theoretical expression.45, 108 The T1 and T2 
relaxation times were measured on a 4.7 T (200Mz) research 
MRI system. Their inverse values 1/T1 and 1/T2 were plotted as 
a function of iron molar concentration for PTMC-b-PGA 
vesicles prepared in WDi condition with USPIOs’ FWR 
ranging from 20 to 70 wt %. The r1 and r2 relaxivities deduced 
from the slopes are reported on Table 4. To assess the 
experimental sensitivity, the solutions were diluted by a factor 
from 20 to 500: no vesicle size variation was observed by DLS 
under such dilutions. While r1 values are weak and almost 
constant (~3 s-1mM-1), r2 values are of the same order of 
magnitude (~100 s-1mM-1) and even larger than for commercial 
T2 contrast agents: these are either individual (AMI-227, 
Ferumoxtran/Sinerem)109 or clustered (AMI-25, 
Feridex/Endorem)110, 111 USPIOs coated with a Dextran 
polymer, the latter being denominated SPIOs because of their 
larger size. The clustering of USPIOs inside objects at a high 
loading density is indeed known to enhance the negative 
contrast for T2-sequence IRM images compared to individual 
USPIOs, as reported for hydrophobic USPIOs in micelles107, 112, 
113 or hydrophilic ones in liposomes114 or electrostatic 
coacervates with charged polymers.115 However, the articles 
that link the experimental r2 values to theory are rather scarce: 
they dealt with SPIOs made of magnetite cores aggregated by 
Dextran of varying sizes116 and more recently with individual 
USPIOs coated by a controlled thickness of silica.117 In the 
present work, we note a steeper slope on Figure 6-A for WDi-
35 (r2=134±2 s-1mM-1) as compared to WDi-20 (r2= 81±1 s-
1mM-1). These relaxivities are both larger than the value 
r2=39±2 s-1mM-1 reported for USPIOs individually dispersed in 
water synthesized by the same aqueous route and of the same 
size distribution.115 For 50 wt % USPIOs in the vesicles, the 
transverse relaxivity reached r2= 173±7 s-1mM-1, but then it 
saturates near this value at r2= 182±4 s-1mM-1 for the highest 
loading content 70 wt %. On the theoretical point, A. Roch et 
al. predicted such a plateau of r2 when increasing the size of 
clusters of USPIOs.116 
 
A
 
B 
 
Figure 6. (A) Transverse relaxation rates (1/T2, s-1) as a 
function of iron concentration (mM) for PTMC24-b-PGA19 
vesicles (WDi) loaded with 20, 35, 50 and 70 USPIO wt %. 
The slopes give the r2 value, respectively 81±1, 134±2, 173±7 
and 182±4 s-1mM-1; (B) T2-weighted MRI images extracted 
from T2 measurements experiment (4.7 T; multiple spin-echo 
2D imaging sequence; TR=10000 ms; inter echo-time, 5 ms; 
number of echo images, 256; FOV, 50×50 mm; matrix, 
128×128; slice thickness, 1 mm) of WDi-70 vesicles at 
different dilution factors. The table gives the molar 
concentrations of iron ions, the total weight concentrations and 
the equivalent molar concentrations of vesicles. 
To evidence the effect of USPIO-loaded vesicles on T2-
weighted MR images, Figure 6-B shows MR images of wells 
B (T) 
(q⊥ - q//) / q0 (%) 
WD15-50 WDi-70 
0.1 11.3 6.8 
0.6 24.4 12.7 
1 26.8 12.0 
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containing increasing concentrations of WDi-70 vesicles. A 
remarkable darkening (i.e. negative contrast enhancement) 
appeared even at low vesicle concentration. The MRI detection 
limit, defined as the copolymer concentration at which the MRI 
signal intensity decreases to 50 % of that of pure water, 107 was 
measured at 6.7 μg/mL for WDi-70 vesicles. Since the molar 
mass of the vesicles measured by SLS is 1.182×107 g/mol 
(Supporting Information S-i), the above sensitivity limit 
corresponds to a vesicle concentration of approximately 0.57 
nM, which is one order of magnitude lower than the 5 nM 
reported for magnetic micelles107 and, to our knowledge, the 
lowest value ever reported. For applications such as the 
evaluation of the bio-distribution or the targeting efficiency of a 
drug conveyed in nano-carriers, the concentration of ferric ions 
may not be the most relevant parameter for the radiologists. 
Therefore the r1 and r2 relaxivities are also expressed in Table 4 
according to the concentration of vesicles in nM to facilitate the 
comparison with other nano-particular contrast agents. Unlike 
the relaxivities per ferric ion which saturate, their values per 
WDi vesicle increase monotonously with the magnetic FWR 
inside the membrane, at an almost constant hydrodynamic size.  
 
 
 
 
 
 
 
 
 
 
Table 4. Longitudinal (r1) and transverse (r2) relaxivities of 
USPIO-loaded WDi vesicles when used as contrast agents for 
MRI at 4.7 T, deduced from the linear fits of the relaxation 
rates 1/T1 and 1/T2 versus molar concentrations both of ferric 
ions (in mM) or of vesicles (in nM). The number of Fe3+ per 
vesicle is the product of the number of USPIOs per vesicle 
(Table 2) by 8200 Fe3+ per USPIO on average.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Doxorubicin loading and release by macroscopic heating 
To determine the feasibility of magnetically controlled drug 
release, a dual loading of USPIOs and of doxorubicin was 
carried out. The nanoprecipitation was performed at pH 10.5 in 
order to deprotonate the DOX (pKa~8.3), thus maximizing the 
loading content (LC=34% without size variation at 50% FWR) 
and extending the release duration as described in a previous 
work.118 For each vesicular dispersion, the USPIO feed weight 
ratio (FWR) was fixed at a value lower than the maximum 
USPIO loading (namely 50 wt % for WDi and 35 wt % for 
WD15) so that space was left in the membrane for DOX 
entrapment. The DOX FWR in the nanoprecipitation mixture 
was then progressively increased. A DOX FWR of 20% was 
selected for both vesicular types since a drug loading at this 
level did not alter the self-assembly of the vesicles 
significantly: Table 5 shows indeed a moderate variation of 
their hydrodynamic size (RH decreases by 16% for WD15 and 
increases by 8% for WDi) and an unchanged surface charge. A 
larger 30% DOX FWR can be sustained by WD-15 vesicles 
without any size change, but for the smaller WDi-50 vesicles it 
leads to a two-fold size increase, presumably due to their larger 
curvature energy already invoked to explained their lower 
deformability under static magnetic field. 
 
 
 
Table 5. Doxorubicin feed weight ratio (FWR), hydrodynamic 
size, polydispersity index and ζ potential of WD15-35 and 
WDi-50 vesicles. The pictures show the corresponding sample 
tubes. 
Sample code RH (nm) N
+3Fe
/vesicle  
ionFe1 3+
r   
(s-1mM-1) 
vesicle1
r   
(s-1nM-1) 
ionFe2 3+
r   
(s-1mM-1) 
vesicle2
r   
(s-1nM-1) 
WDi-20 50 4.5×105 2.8±0.02 1.3±0.01 81±1 37±0.4 
WDi-35 45 6.2×105 3.6±0.08 2.2±0.05 134±2 83±1.2 
WDi-50 47 9.0×105 3.6±0.2 3.3±0.2 173±7 156±6 
WDi-70 52 1.6×106 3.5±0.1 5.5±0.2 182±4 283±7 
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*not determined 
 
After nanoprecipitation with dual-loading in DOX and 
USPIOs, an extensive dialysis against a large volume (4 L) of 
Tris buffer (pH 7.4, 30° C, ionic strength 150 mM) during 4h 
allowed to reduce the pH back to 7.4 and to completely remove 
the unbound drug and DMSO. As for the colloidal stability of 
these dual loaded vesicles, their ζ potential remained strongly 
negative (~ -40 mV). Therefore the corona of PGA chains was 
unaffected, which excludes the precipitation of the USPIOs and 
of the drug onto the hydrophilic chains and proves their 
embedment deeply inside the vesicular PTMC-b-PGA 
membrane. The loading content (LC) and loading efficiency 
(LE) of DOX were determined by spectrophotometry. Values 
obtained for both vesicular dispersions with or without USPIOs 
are gathered in Table 6. A DOX LC around 10 wt% was found 
in all cases, independently of the presence of USPIOs in the 
membrane. Finally, the colloidal stability of the WDi vesicles 
was tested in MEM cell culture medium with fetal bovine 
serum (10% v/v FBS), and no change in size was observed for 
24 hours. 
 
Table 6. Influence of USPIO feed weight ratio on the DOX 
loading content and efficiency into WDi and WD15 vesicles. 
The FWR is in wt % relatively to copolymer in DMSO before 
nanoprecipitation. The LC is measured by spectrophotometry 
after nanoprecipitation and dialysis. The LE is the yield 
LC/FWR.  
Sample 
code 
USPIO 
FWR 
(%) 
DOX 
FWR 
(%) 
DOX 
LC 
(%) 
DOX 
LE 
(%) 
WD15 
0 20 12.5 74 
35 20 9 52 
WDi 
0 20 9.5 47.5 
50 20 12 70 
 
Comparing precisely the DOX loading efficiency between 
dual loaded vesicles and non magnetic ones, we observe that 
LE decreases by 22% for WD15 vesicles, whereas it increases 
by 22.5 % for WDi ones. As a result, the insertion of USPIOs 
and DOX appears competitive in the case of the larger WD15 
vesicles, certainly due to a lack of space in the membrane (the 
difference between Φ
USPIO
mb and its maximal value being only 
2.5 %, see Table 2). On the opposite, the incorporation seems 
cooperative for the smaller WDi vesicles. Such synergetic 
effect of dual loading has already been mentioned for 
copolymer micelles, for which the LC of DOX could be 
enhanced from 3 to 12 wt % by the co-encapsulation with 
hydrophobic USPIOs.36 
Subsequently, in vitro release studies from the several 
prepared vesicular dispersions were monitored in various 
conditions by comparing the absorbance at λmax=485 nm with 
the DOX absorbance calibration curve (after background 
correction). The release kinetics in vitro at 37 °C of WDi-50 
and WD15-35 vesicles fed with 20 wt % DOX appear almost 
similar. As seen on Figure 7 indeed, a plateau at around 50 wt 
% of released DOX was reached in both cases after one day. As 
stated in a previous work on the physicochemical conditions to 
optimize the loading and release of DOX with PTMC-b-PGA 
vesicles (but for a DOX LC of 34 wt % 3 times larger than in 
the present work and without USPIOs),118 temperature has a 
strong influence on the kinetics as well as on the amount of 
drug released: the plateau values at 5°C, 20°C, 37°C and 45°C 
were found respectively equal to 5%, 30%, 60% and 85% of 
the initial DOX load in the vesicles. This temperature 
sensitivity is presumably due to the semi-crystalline nature of 
the PTMC blocks inside membranes evidenced once by 
microcalorimetry83 and in this work by birefringence 
measurement (see Supporting Information S-e). 
On Figure 7, only 15 % of DOX was released after 6 hours 
at 23°C compared to 45 % released after the same time at 37 °C 
thus above the melting temperature of PTMC in the membrane 
of vesicles. 
 
 
 
Figure 7. In vitro release kinetic profiles of USPIO/DOX dual 
loaded vesicles with initial 20% DOX FWR obtained for WDi-
50 (○) and WD15-35 (□) vesicles at 37 °C and for WDi-50 
vesicles at 23 °C (●). In all cases, the release medium was Tris 
10 mM (pH 7.4, ionic strength 150 mM). 
 
 
 
 
Doxorubicin release by magnetic hyperthermia 
Having in mind this thermo-sensitivity of the release rate of 
DOX in vitro from dual-loaded PTMC-b-PGA vesicles, we 
studied the effect of an excitation by an oscillating magnetic 
field of the USPIOs confined in the membranes. Submitted to a 
strong radio-frequency field, USPIOs are known to dissipate 
heat originating from friction losses of their magnetic dipoles 
according to two different relaxation modes: Néel’s relaxation 
consisting in the flips of each dipole between the “easy axes” of 
the crystalline structure and the Brownian rotational diffusion 
of the USPIO grains in the solvent of viscosity η. According to 
a commonly accepted model,50 the specific loss power under a 
Sample 
Code 
DOX 
FWR (%) RH
 (nm) PDI ζ (mV) 
WD15-35 
0 152 0.15 -39.6 
20 124 0.23 -39.3 
30 128 0.16 nd* 
WDi-50 
0 56.5 0.22 -40.8 
20 61 0.15 -42.0 
30 137 0.20 nd* 
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field of frequency fRF and mean intensity H0 expressed in W/g 
writes: 
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Here χ’’(fRF) is the loss term of the dynamic susceptibility of 
an USPIO with specific magnetization mS, mass density d and 
volume VUSPIO. The effective relaxation time τeff corresponds to 
the fastest mode between the two mechanisms participating to 
thermal dissipation. Both of them can be expressed as functions 
of the particle volume: 
 ( )TkVK BUSPIOa0Néel exp×= ττ  (6)  
with s10 90
−≈τ  and 34a J/m10≈K  
and  TkV BUSPIOBrown 3ητ =  (7) 
Although it does not take into account the possible variation 
of relaxation times with the magnetic field intensity,119 this 
model correctly describes the strong dependence of the SLP 
with the size distribution of a suspension of USPIOs53 and 
gives an optimal diameter about 14-15 nm. When USPIOs are 
confined in a viscous environment as in lipid compartments 
inside biological cells (endosomes), membrane, the Brownian 
relaxation mode can be neglected.54, 120 
 
 
Figure 8. Influence of a RF oscillating magnetic field on the in 
vitro release kinetics of WDi-50 vesicles at constant bath 
temperature (23 °C); ●: B=0 T; ■: AC magnetic field (fRF=500 
kHz, B0=2.65 mT).  
Figure 8 displays the kinetic profiles at constant temperature 
23 °C with and without the application of an oscillating 
magnetic field of frequency fRF=500 kHz and mean field 
intensity H0=2.12 kAm-1. Although these field conditions might 
appear weak, they were already over passing by more than a 
factor two the upper dose of RF irradiation fRF×H0<4.85×108 
Am-1s-1 recommended for a human being.121 After 7 hours, the 
DOX release content is multiplied by a factor 2 under RF field 
compared to the same vesicles with USPIOs embedded in the 
membrane but kept away from the coil. The heat produced via 
Néel’s relaxation is believed to increase the fluidity of the 
semi-crystalline polymeric membrane, increasing dramatically 
the diffusion of the encapsulated DOX out of the membrane. It 
should be stressed that we have not observed any macroscopic 
heating of the vesicular dispersion. 122 Even if the global 
temperature of the suspension remained almost unchanged, we 
infer that a local temperature raise around 7°C took place in the 
close vicinity of the membrane (i.e. at the nanometric scale). 
The approximately two-fold enhancement of DOX release rate 
under the RF magnetic field (Figure 8) was indeed of the same 
type than the three-fold enhancement observed when the 
vesicular suspension was heated macroscopically by 14°C thus 
above the melting temperature of the PTMC blocks (Figure 7). 
A control experiment performed by placing the WDi-50 
vesicles during several hours under a constant magnetic field of 
intensity B0=0.4 T showed that a static deformation of the 
vesicles had no impact on the release rate of DOX, thereby 
confirming the necessity to excite the USPIOs at a frequency in 
the RF-range close to their Néel’s relaxation in order to detect 
an effect on the membrane permeability of the vesicles. 
 
 
 
 
CONCLUSIONS 
 
In the present study, the formation of new hybrid vesicular 
self-assemblies from the biodegradable PTMC-b-PGA 
copolymer and hydrophobically coated γ-Fe2O3 nanoparticles 
has been investigated. Hybrid vesicles have been obtained by 
one-step nanoprecipitation, leading to high loading content of 
magnetic nanoparticles (up to 70 wt %) in the membrane 
together with a good control over vesicles’ size and dispersity. 
The vesicular morphology was elucidated by combining light 
and neutron scattering techniques together with electronic and 
atomic force microscopy. These magnetic vesicles exhibited a 
long-term colloidal stability and showed suitable properties for 
biomedical applications: being guided by an external magnetic 
field gradient created by a small permanent magnet, they also 
showed an important contrast enhancement in Magnetic 
Resonance Imaging with a particularly low (sub-nanomolar) 
detection limit. Dual encapsulation of magnetic nanoparticles 
with doxorubicin in the biodegradable vesicular matrix is very 
promising as a versatile method to prepare multifunctional drug 
nanocarriers. The drug release rate could indeed be enhanced 
twice under the application of a RF oscillating magnetic field 
producing a local hyperthermia at the scale of the membranes. 
The well-known hyperthermia effect of USPIOs was utilized 
here in a softer and gentler manner of action on the 
polymersomes’ membrane permeability than by 
thermoablation, which is based on the melting temperature of a 
semi-crystalline polycarbonate block. In future studies, we will 
enhance the RF-triggered release effect by using USPIOs with 
larger diameters (e.g. by a factor 2), which are known to exhibit 
much higher specific loss powers (~100 W/g or more). Apart 
from a higher thermal dissipation acting on the membrane 
fluidity and hence on the diffusion constants, those larger 
USPIOs will be partially ferrimagnetic, i.e. with a magnetic 
anisotropy energy Ea>kBT. This might introduce another 
mechanism of membrane permeation, by direct rotation of the 
grains at the frequency of the oscillating magnetic field. Such a 
mechanism would be reminiscent of the “molecular drill” 
effect123-125 predicted long ago for lipid bilayers under 
mechanical stress by adsorption onto a corrugated surface. 
To summarize, by exhibiting biocompatibility of the 
polymeric matrix, ease of preparation, contrast enhancement in 
MRI and triggered release under RF oscillating field, those 
hybrid vesicles are good candidates for the magneto-
chemotherapeutic treatment of cancer. This work evidenced for 
the first time the concept of multi-functional polymersomes to 
combine imaging and therapy, opening new avenues to 
improve cancer treatments and to understand their mechanisms. 
The impact of such theranostic systems on tumor regression is 
currently under investigation.  
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EXPERIMENTAL DETAILS 
 
Materials and syntheses 
Polymer, drug and buffers. PTMC24-b-PGA19 diblock 
copolymer was synthesized by ring-opening polymerization 
(ROP) of γ-Benzyl-L-glutamate N-carboxyanhydride initiated 
by an amino functionalized PTMC macroinitiator upon a 
previously published method.82 All the experiments were 
conducted on a PTMC24-b-PGA19 (Mn = 4900 g/mol) block 
copolymer which presents a hydrophilic weight fraction of 50 
wt % and a molar mass dispersity of 1.15. The solvent for 
nanoprecipitation (DMSO) was used without prior purification. 
Doxorubicin hydrochloride (CAS: 25316-40-9) was supplied 
by Discovery Fine Chemicals (Wimborne, UK). DOX was 
reconstituted in DMSO, stored at 5 °C and used within one 
month. Sodium chloride, Tris-HCl and Tris base were provided 
by Sigma. 
Iron oxide nanoparticles. Superparamagnetic nanoparticles 
of maghemite (γ-Fe2O3), also called USPIOs, were synthesized 
by alkaline coprecipitation of iron(II) and iron(III) salts75 and 
sorted according to their size by fractionated phase 
separations.76 Briefly, the ionic strength was increased to 
screen the electrostatic interactions between the nanoparticles 
and obtain successive fractions of narrower size distribution, as 
measured all along the sorting process by vibrating sample 
magnetometry (VSM) and on the final sample by scattering 
techniques (SLS, DLS and SANS). For dispersion in CH2Cl2, 
the surface of the nanoparticles was grafted by the anionic 
surfactant Beycostat NB09 (CECA, Arkema group, France) 
used to disperse inorganic pigments in aromatic and chlorinated 
oils (but insoluble in aliphatic solvents), which is a mixture of 
mono- and diesters of phosphoric acid. The grafting procedure 
(30 min at 60°C, 20 mol% relatively to iron) was previously 
described.77 
 
Preparation of empty, USPIO loaded and DOX/USPIO 
dual-loaded vesicles 
Carbonate buffer (pH 10.5, 50 mM, 4.5 mL) was added onto 
PTMC24-b-PGA19 (5 mg) dissolved in DMSO (0.5 mL) under 
magnetic stirring (1000 rpm) in a plastic tube (1.5 cm 
diameter), leading to a homogeneous dispersion of vesicles. A 
syringe pump controlled the water flow rate during injection. 
Two addition durations (5 seconds and 15 minutes 
respectively) of water solution into DMSO were used in order 
to tune the final average vesicle size. The resulting samples 
were respectively called WDi (for “instantaneous”) and WD15. 
The organic solvent was then removed by extensive dialysis 
against 4 L Tris buffer replaced at least twice (10 mM Tris, pH 
7.4, 25 °C ionic strength 150 mM). 
USPIO loading was performed at different feed weight ratios 
(FWR) (wt USPIO/wt copolymer) using the same nanoprecipitation 
method. A negligible volume of USPIO suspension in CH2Cl2 
(e.g. VCH2Cl2/Vwater=0.55% for wtUSPIO/wtpolymer=50 %) was 
added into the DMSO/copolymer solution prior to the addition 
of water. For DOX/USPIO dual-loaded vesicles, doxorubicin 
hydrochloride was at first solubilized in the DMSO/copolymer 
solution at 2 mg/mL before mixing with the USPIOs. After 
water addition, organic solvent and free DOX were removed by 
dialysis for 4h with a membrane of 3500 g/mol MWCO against 
4 L Tris buffer (10 mM Tris, pH 7.4; 30 °C, ionic strength 150 
mM). The doxorubicin loading content (LC) was determined 
after vesicle rupture using sonication in a mixture containing 80 
% volume of DMSO. This solvent mixture induced the 
aggregation of USPIOs that were then separated by 
centrifugation (1h, 10000 rpm). Then the titration of DOX was 
performed from the UV absorbance at λmax =485 nm using the 
known value for doxorubicin in a DMSO/Tris buffer (80/20 
v/v) mixture as calibration (see Supporting Information S-g). 
 
Experimental Methods 
Dynamic light scattering (DLS) and static light scattering 
(SLS) were performed using an ALV Laser goniometer, which 
consisted of a 35 mW HeNe linear polarized laser with a 
wavelength of 632.8 nm and an ALV-5000/EPP Multiple Tau 
Digital correlator with 125 ns initial sampling time. The 
samples were kept at constant temperature (25 °C) during all 
the experiments. The accessible scattering angle range ranged 
from 30° up to 150°. However, most of the dynamic 
measurements were carried out at 90°. Aliquots of the samples 
(1 mL in a 10 mm diameter cylindrical glass cell) were 
immersed in a filtered toluene bath. The data acquisition was 
done with the ALV-Correlator Control software and the 
counting time for DLS was fixed for each sample at 30 s. To 
perform light scattering in static mode, the differential 
refractive index increment dn/dc of PTMC24-b-PGA12 vesicles 
in buffer was measured over a concentration range from 0.2 to 
1 mg/mL by means of a differential refractometer (Wyatt 
Optilab rEX) operating at a wavelength of 658 nm and at 25°C. 
A dn/dc value of 0.3454 ± 6 10-4 mL/g was obtained for WDi 
vesicles loaded with 50 wt % USPIOs, which is larger than the 
value dn/dc=dn/dΦ/dUSPIO=1.08/5.1=0.21 mL/g reported for 
pure USPIOs coated with the same Beycostat surfactant.126 The 
mean hydrodynamic radii and polydispersity indexes (PDI) 
were determined using the 2nd order cumulant analysis. 
Isotropic Small Angle Neutron Scattering (SANS) 
measurements were performed on the PAXY spectrometer of 
the Laboratoire Léon Brillouin (CEA-Saclay, France) equipped 
with a two dimension detector made of 128×128 cells. We used 
two configurations: the first one with a sample-to-detector 
distance of D=6.7 m and a neutron wavelength of λ=10 Å to 
cover a q range of 2.5×10-3 – 2.5×10-2 Å-1; the second one with 
D=2 m and λ=6 Å to cover a q range of 2×10-2 – 0.2 Å-1. Full 
angular averaging of the detector cells at constant q was 
realized for the scattering patterns with the PASINET software 
available at www-llb.cea.fr.  
The samples were prepared by nanoprecipitation, 
centrifuged and redispersed in the desired mixture of 
hydrogenated and deuterated solvents at a final concentration 
of 10 mg/mL. Three solvents were used in order to match the 
scattering length densities of the various components of the 
loaded magnetic polymersomes and to focus the contrast on 
selected features (see Supporting Information S-a). The 
magnetic scattering length density of the USPIOs estimated 
from the magnetization at saturation MS and the volume of the 
nanoparticles was ρmagUSPIO ≈1010cm-2. One solvent was pure 
H2O, which allowed observing mainly the nuclear scattering of 
USPIO but also in a reduced way the copolymer signal. Pure 
D2O almost matched the nuclear signal of the USPIOs: this 
scattering intensity revealed the fluctuation of the polymeric 
membrane together with the magnetic scattering of the 
USPIOs. Finally, the use of a H2O/D2O (65.6/34.4 v/v) mixture 
matching the copolymer scattering length density enabled to 
focus on the nuclear scattering of the USPIOs only. The 
calculated contrast of neutrons scattering-length densities 
between γ-Fe2O3 and this H2O/D2O mixture was Δρ =5×1010 
cm-2. SANS measurements were done in 5 mm thick quartz 
cuvettes for D2O or 1 mm thick ones for H2O and H2O/D2O 
solvents to minimize the incoherent scattering. All the scattered 
intensity curves were corrected from the incoherent background 
of their proper solvents. They have been also normalized by the 
incoherent signal delivered by a 1 mm gap water sample in 
order to account for the efficiency of the detector cells. 
Absolute values of the scattering intensity, I(q) in cm-1, were 
obtained from the direct determination of the number of 
neutrons in the incident beam and the detector cell solid 
angle.127, 128  
Here we mainly discuss the SANS signal obtained with 
USPIO loaded polymersomes’ suspensions in the H2O/D2O 
mixture, which matches the copolymer. Following a method 
used for other kinds of nanocomposites made from colloids or 
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micelles,86, 87 the SANS curves of the USPIO loaded vesicles 
were divided by the volume fraction ФUSPIO and by the form 
factor of the USPIO nanoparticles measured independently on a 
dilute solution. This procedure yields the intra-aggregate 
structure factors Sintra(q) of the USPIO nanoparticles, which tell 
us about their spatial arrangement into aggregates of a given 
geometry (micellar, vesicular, fractal...). The calculated form 
factor of hollow shells took into account their radius, 
membrane thickness, dispersity and the experimental resolution 
of the spectrometer.88 
Anisotropic SANS measurements. The sample was placed 
between the poles of an electromagnet producing a 
homogeneous magnetic field at the sample position, as checked 
by a Hall probe (Walker scientific). The solvent used was pure 
H2O which does not match the nuclear scattering length density 
of the copolymer but is insuring a negligible magnetic 
scattering of iron oxide (Δρ =1.4.1010 cm-2 between H2O and 
the magnetic scattering length density of iron oxide). 
Nevertheless, the nuclear contrast of the USPIO (Δρ =7.5.1010 
cm-2) remained still three times larger than the one of the 
copolymer (Δρ =2.5.1010 cm-2). The scattering intensity being 
proportional to the square of the contrast, we can neglect the 
contribution arising both from the copolymer and from the 
magnetic moments of the USPIOs in the total scattered 
intensity. An anisotropic analysis was applied to the scattering 
patterns obtained under magnetic field. To obtain anisotropic 
curves with a good statistics, the intensity on the 2D-detector 
was averaged in angular sectors either [-30°; 30°] along the 
field direction where the scattered intensity was weaker, and 
thus called I//(q), or [-15°; 15°] around the perpendicular 
direction and denoted I┴(q). 
Magnetization measurements. The magnetization curves of 
the maghemite USPIOs and of the USPIO-loaded vesicles were 
determined using a home-made vibrating sample magnetometer 
(VSM) under an applied magnetic field up to 0.93 Tesla. From 
the shape of the magnetization versus field intensity curve 
M(H), the size distribution of the magnetic cores was obtained 
by convolving the first order Langevin’s law of paramagnetism 
L1(ξ)=M/ΦmS=coth(ξ)-1/ξ with ξ= µ0mSπD3H/6kBT (kB is the 
Boltzmann constant and µ0 the vacuum magnetic permeability) 
with a Log-normal probability law of median diameter 
DmagUSPIO and width σ, defined as the standard deviation of the 
distribution Ln(D/DmagUSPIO).80, 81 
Magnetic birefringence. The setup that has been described 
precisely129 was improved for temperature control. Briefly, it 
consisted in an electromagnet used to magnetically induce a 
macroscopic birefringence in a magnetic colloid made of 
birefringent magnetic nanoparticles (or made of nano-objects 
filled with such MNPs). This induced birefringence was then 
measured by sending a linearly polarized He/Ne laser beam (10 
mW) though the birefringent sample and analyzing the 
transmitted light with a second polarizer and a photodiode. A 
photo-elastic modulator and a lock-in amplifier were used to 
increase the setup sensitivity, the resulting AC and DC signals 
being related respectively to the levels of birefringence and 
dichroism under the applied magnetic field. To perform 
measurements at various controlled temperatures, the glass cell 
containing the sample was put in a specifically designed copper 
cell, which temperature was regulated using a Pt100 
temperature probe and Peltier devices connected to a current 
source and externally controlled by a PC using NI LabVIEW. 
Magnetophoresis. A magnetophoretic experiment consists in 
measuring the constant velocity reached by magnetic objects in 
a magnetic field of increasing intensity (spatial gradient), 
applying on them a magnetic force balanced by a viscous drag 
one.62, 92, 93, 95, 97, 104 In our case, a drop of an aqueous vesicle 
solution was placed between a glass slide, a 200 μm spacer and 
a cover slip to prevent evaporation and convection. This cell 
was mounted on the stage of an inverted optical microscope 
(Leica DM-IL). A strong NdFeB magnet of 22 mm diameter 
and 10 mm thickness (Aimants Calamit, France) was held by a 
clip 6 mm away from the centre of the focus plane of the 
microscope. Bright field optical microscopy images taken with 
a 40X objective were recorded with a digital camera (Infinity3-
1U, Lumenera, Ottawa, Ontario, Canada) enabling pixel-
binning to enhance the recording rate. The magnetophoretic 
trajectories of about 280 vesicles exhibiting a biased thermal 
motion toward the magnet were recorded at video rate (24 
frames/s). Three sequences (each containing 240 frames of 
800x600 pixels) were analyzed off-line using the 
“ParticleTracker” plug-in developed by the MOSAIC group at 
ETH Zürich for the free image processing software ImageJ 
with the following parameters: Kernel radius= 6, Cutoff 
radius= 0.0, Percentile= 0.6, Displacement= 5.0, Linkrange= 
120).130 Each stack of 240 frames (10 s duration) necessitated a 
computing time of 16 min with a 64-bit desktop PC with 4Gb 
RAM. For theoretical calculations of the number of USPIOs 
per vesicle from the average drift velocity, a magnetic field 
gradient dB/dz=18.5 mT/mm and an average magnetic flux 
density B0=µ0H0=174 mT were used as reported for an identical 
magnet.93 
MRI Relaxometry. For different USPIO-vesicle 
formulations, T1 and T2 relaxivities were measured at 4.7 T 
(fLarmor=200 MHz) on a research MRI system (Bruker Biospec 
47/50, Ettlingen, Germany) at 20°C. The transverse T2 
measurements were acquired using a multiple spin-echo 2D 
imaging sequence (TR=10000 ms; inter echo-time, 5 ms; 
number of echo images, 256; FOV, 50×50 mm; matrix, 
128×128; slice thickness, 1 mm). The longitudinal relaxation 
times T1 were obtained out using an inversion-recovery 2D 
imaging sequence (increment of inversion delay: 34 ms with 
456 increments) followed by a RARE imaging sequence 
(RARE Factor: 8; TR/TEeff : 10000/7.7 ms; FOV: 50×50 mm; 
matrix: 128×128; slice thickness: 1 mm). The relaxivity values 
r1 and r2 were calculated by linear fits of the relaxation rates 
1/T1 and 1/T2 (s-1) vs. iron concentration (mM) or vesicle 
concentration (nM). 
Iron titration. The total iron concentration (mol/L) was 
determined by atomic absorption spectroscopy (AAS) with a 
Perkin-Elmer Analyst 100 apparatus after degrading the 
USPIO-loaded vesicles in boiling HCl (35%). The volume 
fraction of iron oxide was deduced from the molar mass (159.7 
g/mol) and mass density (5.1 g/cm3) of γ-Fe2O3, i.e. 
numerically ФUSPIO (% v/v) = 1.577 [Fe] (mol/L). 
Electrophoretic mobility. Empty and loaded vesicles were 
analyzed with a ZetaSizer NanoZS (Malvern Instruments, 
Worcestershire, UK). The electrophoretic mobilitity (μ) was 
converted into zeta potential (ζ) using Smoluchowski’s 
approximation, which is valid since the vesicles are all much 
larger than the Debye length κD-1 of the buffers (κDDH>>1). All 
the measurements were performed at 25° C and the data were at 
least the average of triplicate values.  
Transmission electron microscopy. TEM images were 
recorded on a Hitachi H7650 microscope working at 80 kV 
equipped with a GATAN Orius 11 Megapixel camera. Samples 
were prepared by spraying a 1 mg/mL solution of the vesicles 
onto a copper grid coated with carbon (200 mesh) using a 
homemade spray tool. 
TEM with negative staining. USPIO-loaded polymer 
vesicles (0.04 mg/mL in water) were adsorbed on a carbon-
coated EM grid and negatively stained with 1% uranyl acetate. 
TEM was performed with a CM120 (FEI) microscope.  
Cryo-TEM imaging. USPIO-loaded polymer vesicles (2 
mg/mL in water) were deposited on an EM grid coated with a 
perforated carbon film. After draining the excess liquid with a 
filter paper, grids were quickly plunged into liquid ethane and 
mounted onto a Gatan 626 cryoholder. TEM was performed 
with a Tecnai F20 (FEI) microscope operated at 200 kV. The 
images were recorded with a 5 Megapixel USC1000-SSCCD 
camera (Gatan). 
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Atomic force microscopy. AFM images were recorded in air 
with a Nanoscope IIIa microscope operating in dry Tapping-
mode. The probes were commercially available silicon tips 
with a spring constant of 42 N/m, a resonance frequency of 285 
kHz and a typical radius of curvature in the 10-12 nm range. 
Freshly cleaved mica was used as sample substrate materials. 
For the observation of empty and USPIO loaded vesicles, 
sample solutions in water at concentrations of 0.01 mg/mL and 
0.1 mg/mL respectively were deposited on the substrate (20 
µL) and dried under vacuum at 40 °C for 12 hours. 
In vitro DOX release. The required quantity of drug-loaded 
vesicles was poured into a dialysis tubing (Spectra/Por Float-A-
Lyzer, 50 000 g/mol MWCO, 10 mm diameter, 10 mL 
volume). The dialysis membrane filled with 5 mL of DOX 
loaded polymersomes was introduced into a bath of 50 mL 
buffer (10 mM Tris, pH 7.4, ionic strength 150 mM). At each 
sampling point, sink conditions were maintained by replacing 2 
mL of the outer medium reservoir by fresh buffer. Because of 
the known sensitivity of DOX to degradation, the amount of 
released drug was calculated by the difference between the 
initial drug content and the drug remaining at each sampling 
point in the suspension of vesicles. More precisely, a 
spectrophotometric measurement at λmax= 485 nm was 
performed on an aliquot taken inside the dialysis bag. To take 
into account absorption by iron oxide and turbidity, the DOX 
concentration was calculated from the measured absorbance 
using a calibration curve in water after subtracting the 
absorbance value of similar USPIO-loaded vesicles. Another 
method consisted in redispersing the vesicles inside the aliquots 
into individual components (USPIOs, molecular DOX and 
copolymer unimers) in a DMSO:Tris (80:20) mixture before 
measuring the absorbance. Their calibration curves being 
provided as Supporting Information S-g, both methods led to 
comparable results, attesting the reliability of the 
measurements. 
In vitro DOX release under an oscillating RF magnetic field. 
We used a RF generator built at the ICMCB laboratory in 
Pessac, France.131, 132 An alternating magnetic field with 
fRF=500 kHz frequency and mean field intensity H0=2.12 kA/m 
(induction B0=µ0H0=2.65 mT) was generated by a 28-turn 
pancake coil (20 cm height) cooled by a water circulation. The 
frequency was adjusted by a Celes inductor C97104 (Celem 
Passive Components, Israel). The electrical current was 
provided by a wave generator (FI1202, Française 
d’Instrumentation, France) connected to a power amplifier (AR 
Worldwide 800A3, 10kHz–3MHz, EMV, France). The vesicles 
were prepared as usual then diluted by a factor 2. A dialysis 
bag filled with half of the dispersion (4 mL) was placed inside 
a plastic cylindrical vessel filled with 30 mL Tris buffer, fitting 
inside the coil of the above described setup. The release profile 
of the other half was performed in the same conditions of 
volumes, vessels and ambient temperature of the room (23°C), 
but kept far away from the magnetic field as a control 
experiment of release without RF field. In particular, both 
reservoirs of release medium were not stirred to avoid any 
parasitic heating due to the presence of a magnetic bar inside 
the RF magnetic field. 
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S-a. Contrasts and treatments of the SANS data of γ-Fe2O3 USPIOs embedded within the 
membrane of poly(trimethylene carbonate)-b-poly(L-glutamic acid) (PTMC-b-PGA) vesicles. 
The scattering length in neutron scattering is quantifying the strength of the interaction of a neutron 
wave with a given nucleus. Thus every element is characterized by a particular scattering length. The 
overall scattering length of a molecule (b) is defined as the sum of the scattering lengths of the 
different elements present in the molecule. Scattering length densities of the solvents, copolymer and 
maghemite related to their molar volumes are presented in Figure S-1. 
 
Figure S-1. Scale of the scattering lengths densities of solvents, block copolymer and maghemite. 
For magnetic molecules, a magnetic scattering length density corresponding to the interaction 
between the magnetic moment carried by neutrons and magnetic induction due to magnetic moments 
carried by the molecules has to be considered. It can be calculated knowing the number of Bohr 
magnetons per unit volume of the magnetic molecule (numerically ~38 µB/nm3 for the USPIOs used in 
this study according to VSM) and the scattering length of the moment of one Bohr magneton, 2.7×10-
13 cm/ µB.  
When a particular entity (molecule, micelle...) is immersed in a solvent, its nuclear contrast factor δ 
is defined as the square of the difference between the scattering length density of the entity (b) and that 
of the solvent (b0): 
2
0
2 )( bb −∝δ  (S-1) 
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The scattered intensity by an ensemble of symmetric objects (as micelles, spheres) in solution is 
defined for each scattering vector q as: )]()([)( 2 qSqPΦqI δ∝  (S-2) 
where Ф is the volume fraction of the objects in the solution, P(q) the form factor of the objects and 
S(q) their structure factor (revealing the interaction between different them). 
 
In our case where USPIOs are embedded in block copolymer vesicles in solution, the scattered signal 
is complex since multiple interactions exist between different γ-Fe2O3 nanoparticles, different 
copolymer chains but also cross-interactions between nanoparticles and copolymers. By omitting the 
signal due to magnetic fluctuations, the scattered intensity of such a system can be written as the sum 
of complex partial structure factors weighted by the corresponding contrasts: 
)()()]()([)(
3232323232 Ocopo/FecopoOFecopocopo
2
copointraOFeOFe
2
OFe qSqSΦqSqPΦqI δδδδ ++∝  (S-3) 
This equation can be simplified when the solvent is matching the scattering length density of the 
copolymer or of the USPIOs. For instance, by using as a solvent a particular mixture of H2O/D2O such 
as 0)( OO/DHcopo 22 =−∝ bbcopoδ , it is possible to remove all the contributions of the copolymer. 
Equation (S-3) thus becomes: 
 )]()([)( intraOFeOFe
2
OFe 323232
qSqPΦqI δ∝  (S-4) 
The structure factor between γ-Fe2O3 nanoparticles is now defined as: 
 
2
OFeOFeOFe
int
323232
)(
)()(
δqPΦ
qIqS ra =  (S-5) 
where PFe2O3(q) is the form factor of γ-Fe2O3 nanoparticles. The latter can simply be obtained from 
the scattering of a dilute solution of USPIOs (Equation (S-2) with S(q)=1). 
In the case of an assembly of magnetic objects, Equation (S-3) is even more complex since the 
organization of magnetic moments carried by the γ-Fe2O3 nanoparticles gives rise to an additive signal 
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with a magnetic contrast. By using several contrast matching conditions, it will be possible to better 
describe the organization of such complex structures. 
 
S-b. Shape anisotropy of the vesicles and variation of their membrane thickness under magnetic 
field 
In order to study the deformation of the vesicles under a constant magnetic field, the anisotropic 
SANS patterns were averaged in angular sectors either [-30°; 30°] along the field direction or [-15°; 
15°] around the perpendicular direction, as represented by a mask on Figure S-2-A. The resulting 
curves I//(q) and I┴(q) were compared by two different methods. At first, we considered a given 
intensity (e.g. 6 cm-1) and we calculated an anisotropic factor (q⊥ - q//) / q0 (%) (Figure S-2-B). 
A  B  
Figure S-2. Masks used to average an anisotropic SANS pattern under a horizontal magnetic field in 
two perpendicular angular sectors (A). Intensity curves I//(q)and I┴(q) obtained in the q range 5×10-3 – 
3×10-2 Å-1 (B). For a given intensity (horizontal line here at 6 cm-1), corresponding wave vectors q// 
and q┴ were extracted and compared to the value q0 that would be obtained by an isotropic averaging. 
B = 1 T 
B 
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Then for each direction, we calculated a membrane thickness respectively δ// and δ┴ by plotting 
Kratky-Porod’s asymptotic law Ln[q2 I(q)] ~ -q2δ2/12 in the low-q regime. We recall that the solvent is 
pure H2O, allowing to observe mainly the nuclear scattering of the USPIOs. Consequently, the 
membrane thickness calculated here is the inorganic layer, which does not take into account the outer 
leaflet of the copolymer bilayer. Thus variations of I(q) in both directions translate a reorganization of 
the USPIOs in the vesicle assembly. 
A  B  
Figure S-3. Variation of membrane thicknesses δ// and δ┴ of WD15-50 vesicles in light water 
calculated in Kratky-Porod’s regime (A). Sketch representing the possible deformation of the vesicle 
into an ellipsoid elongated along the field, combined with the migration of the USPIOs from the 
magnetic poles towards the equator in order to minimize their magnetic dipolar energy (B). 
 
The variation of δ// and δ┴ as a function of the magnetic field intensity plotted on Figure S-3-A can 
be interpreted in several manners. One possibility consists in the stretching of the membrane near the 
magnetic poles (i.e. the portions of the shell almost perpendicular to the magnetic field) due to an 
overall deformation of the vesicle into an elongated (prolate) ellipsoid. Almost equivalently, the 
apparent decrease of membrane thickness δ// could also signify that the USPIOs move away from the 
magnetic poles, where dipolar repulsions between them are the strongest. In the meantime, the 
apparent thickness of the remaining parts of the membrane and especially near the equator δ┴ increases 
(up to 18 nm at 0.6 T). In this model, the USPIOs would concentrate in the regions of the membrane 
with a normal perpendicular to the field, where their dipolar interactions can be attractive. A 
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combination of the two interpretations (ellipsoidal deformation and migration of the USPIOs in the 
fluid membrane) is sketched on the Figure S-3-B. It is mainly in the field interval 0.1 – 0.6 T that the 
membrane thicknesses δ// and δ┴ together with the anisotropy factor (q⊥ - q//) / q0 at 6 cm-1 vary, before 
remaining almost constant up to 1 T. The plateau values reached between 0.6 T and 1 T are likely due 
to the saturation of the magnetic moment of the vesicle above B ≈ 0.7 T as measured by VSM (Figure 
S-4). 
 
 
S-c. SANS study of magnetic vesicles in D2O. 
Pure D2O almost matches the nuclear signal of USPIOs, so that the scattering intensity reveals the 
fluctuation of the polymeric membrane together with the magnetic scattering of iron oxide. A 
correlation bump progressively appears on Figure S-4 with increasing FWR of USPIOs. The 
associated correlation distance (similar as the one observed in the solvent H2O/D2O mixture matching 
the copolymer) is thought to translate the correlation between the holes left by the USPIOs in the 
polymer membrane.  
 
Figure S-4. SANS curves of PTMC24-b-PGA19 vesicles prepared under WDi conditions with 
increasing USPIO loading centrifuged then dispersed in D2O at a concentration of 10 mg/mL. 
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S-d Magnetization of USPIO-loaded vesicles 
The magnetization curve of vesicles loaded with 50 wt% USPIO (WD15-50) was measured by VSM 
and compared to the starting γ-Fe2O3 USPIO dispersion in CH2Cl2 (Figure S-5). The absence of 
hysteresis in the experimental data confirmed the superparamagnetic behavior of the USPIOs 
embedded in the hydrophobic PTMC membranes of the vesicles. The slight magnetization decrease for 
magnetic vesicles compared to bare USPIOs (ferrofluid) was thought to arise from a much smaller 
signal/noise ratio due to the overall iron concentration during analysis which is about 200 times lower 
for USPIO-vesicles. Both USPIO ferrofluid and USPIO-loaded vesicles magnetization curves were 
fitted according to Langevin’s law of paramagnetism, each USPIO being a giant magnetic 
monodomain with an average magnetic dipole of 8200 µB, which is also the approximate number of 
Fe3+ ions per USPIO (see below). 
 
Figure S-5. Vibrating Sample Magnetometry measurements. Magnetization (M) of USPIOs dispersed 
in CH2Cl2 (squares) and of vesicles loaded with 50 wt % USPIOs (WD15-50) normalized by the value 
of magnetization at saturation (MS) for magnetic field intensities up to 0.93T (increasing and 
decreasing). On the magnetization curve of WD15-50 vesicles, the plateau value MS/ΦmS allowed to 
determine a concentration of USPIOs 0.43 g/L very close to the expected one 0.429 g/L, taking into 
account the USPIO FWR and the dilution effect during dialysis. Langevin’s fits are given in plain line. 
On those curves, the Langevin’s law was convolved with a Log-normal probability law of median 
diameter DmagUSPIO=6.3 nm and width σ=0.22, defined as the standard deviation of the distribution 
Ln(D/DmagUSPIO). Due to the tail of this distribution law towards large diameters, the weight averaged 
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diameter Dw=<D4>/<D3> was shifted to a larger value compared to the median value DmagUSPIO. Simple 
statistics gives Dw=DmagUSPIO×exp(3.5σ2)=7.5 nm, which is intermediate between the values 
determined by scattering experiments 2RGUSPIO=6.1±0.12 nm and 2RHUSPIO=9.4±0.14 nm. The weight 
average volume needed in the magnetophoresis experiment is thus VUSPIO =πDw3/6=220 nm3. From the 
mass density 5.1 g/cm3 of maghemite, a molar mass MwUSPIO=670 kg/mol was calculated. This 
estimate compares well with the experimental value MwUSPIO=675 kg/mol measured by a Zimm-plot of 
a series of dilutions of the USPIOs in toluene at several concentrations and scattering angles from 50° 
to 130°. The molar mass of γ-Fe2O3 being equal to 159.7 g/mol, each USPIO contains on average 8400 
Fe3+ ions. Inferring a typical value of the anisotropy constant of maghemite Ka≈104 J/m3, the magneto-
crystalline energy Ea=KaVUSPIO was estimated around 0.5kBT. Therefore these magnetic nanoparticles 
exhibit a pure superparamagnetic behavior, with no ferromagnetic contribution originating from the 
tail of the Log-normal distribution towards the largest diameters. As for their specific magnetization, 
we found mS=2.8×105 A/m. For comparison with the literature in CGS units, it corresponds to 
mS=3520 Oe and mS/4π=280 emu/cm3 or 55 emu/g. This value is about 30% less than for bulk 
maghemite (mS=4.2×105 A/m), this discrepancy being ascribed to the magnetic disorder of iron spins 
at nanoparticles’ surface. 
S-e. Magnetic birefringence of USPIO-loaded vesicles 
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Figure S-6. A. Birefringence curve as a function of the applied magnetic field for WD15-15 
polymersomes at 8mg/mL inside a glass cuvette of 3 mm light path at 19°C and 64°C. B. Raw 
birefringence signal at constant magnetic field H=2100 Oe during a cooling ramp from 64°C to 19°C. 
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A suspension of WD15-15 vesicles was measured with the experimental setup designed to measure 
the birefringence as a function of magnetic field intensity and at regulated temperature. While the 
curve at 64°C can be adjusted with a 2nd order Langevin’s function (with a parabolic variation at low 
field and saturating at large fields at a plateau value), the birefringence appears much higher at 19°C, 
which cannot be accounted simply by a lower thermal agitation of the USPIOs. The raw optical signal 
on the photodiode is also plotted at a constant magnetic field intensity (0.21 Tesla) while decreasing 
slowly the sample temperature at 1°C/min. The observed peak that compares well with Tmelting=36°C 
measured for PTMC-b-PGA vesicles by micro-Differential Scanning Calorimetry in a previous work 
corresponds to a burst of birefringence thought to arise from crystalline spherulites of PTMC inside the 
membranes. 
S-g. Calibration curves for DOX titration by spectrophotometry 
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Figure S-7. A. Calibration curves of the absorbance at 485 nm vs. doxorubicin concentration either 
on intact vesicles in Tris buffer (blue square) or on disrupted vesicles (red circles) in DMSO/Tris 
buffer (80:20 v/v). B. Absorption spectra of PTMC-b-PGA vesicles loaded at pH 10.5 with increasing 
amounts of doxorubicin (FWR values) after dialysis at pH 7.4. Once normalized by the DOX 
concentration, the curves can be superposed and compared to the spectra of free doxorubicin in its 
protonated (red circles) and deprotronated (blue square) forms, respectively solubilised in Tris pH 7.4 
and carbonate pH 10.5 buffers. The shoulder around 600 nm typical of the alkaline DOX progressively 
disappeared from the vesicles’ curves when FWR increases, as expected from the dilution effect of 
weak acids in solution. 
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The concentration of doxorubicin was determined by two different methods allowing a cross check. 
Firstly, absorbance at λmax = 485 nm was measured on aliquots of vesicles in the release buffer after 
each sampling point. Secondly, the dual loaded USPIO/DOX vesicles were broken by sonication in a 
mixture of DMSO and Tris buffer (80:20 v/v) before measuring the absorbance at 485 nm. 
S-h. Other Atomic Force Microscopy Images 
 
 
 
Figure S-8. AFM Tapping Mode™ phase images of vesicles deposited on mica. Images show pure 
PTMC24-b-PGA19 vesicles (WDi-0) on the left and USPIO-loaded ones (WDi-50) on the right. 
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The discrepancy between the diameters around 200 nm appearing on the AFM images and the 
hydrodynamic sizes (134 nm for WDi-0 and 94 nm for WDi-50) is ascribed to the total spreading of 
the vesicles onto the mica substrate that we describe by the following sketch: 
      
The same spreading effect is invoked to explain the larger diameters measured on some of the TEM images (those of 
samples deposited by spraying) compared to hydrodynamic sizes (Figure 2A, B and C). 
 
 
 
S-i. Static Light Scattering 
 
Figure S-9. Zimm plot of WDi-50 vesicles’ suspensions at five different concentrations ranging from 
0.2 to 1 mg/ml. The extrapolated intercept leads to a molar mass 1.182×107 g/mol. 
 
 
